The Leimkuhler Grimes Group is interested in questions at the interface of chemistry and biology. Our lab uses carbohydrate synthesis, biochemistry, molecular biology and bacterial engineering to investigate activation of the human innate immune system. Our work has implications for understanding inflammatory bowel disease and other human diseases.
Get in Touch
Learn more about our team of graduate students and undergraduate researchers.
In addition to running the Leimkuhler Grimes Group, Professor Catherine Leimkuhler Grimes co-directs the Chemistry-Biology Interface (CBI) program at the University of Delaware.